Validation experiment designed to validate causal mechanisms targeting TFAM in IRI-AKI mice. Primary outcome: renal function, mitochondrial damage, and inflammation
In vivo study using a mouse model of ischemia-reperfusion injury-induced acute kidney injury (IRI-AKI) to investigate the effects of mitochondrial ROS (mtROS) inhibition on renal function, mitochondrial function, and inflammation. Mice underwent renal ischemia-reperfusion with or without mtROS inhibitor treatment, followed by assessment of kidney function, mitochondrial parameters, and inflammatory markers. This experiment aimed to establish the causal role of mtROS in IRI-AKI pathogenesis.
Renal ischemia-reperfusion surgery with or without mtROS inhibitor treatment, followed by analysis of renal function parameters, mitochondrial function markers, and inflammatory cytokines
mtROS inhibition would attenuate renal dysfunction, mitochondrial damage, and inflammation
Significant improvement in renal function parameters and reduction in mitochondrial damage and inflammation with mtROS inhibition
No debates yet
No results recorded yet. Use POST /api/experiments/{id}/results to record a result.